Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models

Retinal vascular leakage, inflammation, and neovascularization (NV) are features of diabetic retinopathy (DR). Fenofibrate, a peroxisome proliferator–activated receptor α (PPARα) agonist, has shown robust protective effects against DR in type 2 diabetic patients, but its effects on DR in type 1 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Hu, Yang, Lin, Mingkai, Jenkins, Alicia J., Keech, Anthony C., Mott, Robert, Lyons, Timothy J., Ma, Jian-xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526044/
https://www.ncbi.nlm.nih.gov/pubmed/23043158
http://dx.doi.org/10.2337/db11-0413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526044/
https://www.ncbi.nlm.nih.gov/pubmed/23043158
http://dx.doi.org/10.2337/db11-0413

Ejemplares similares